参考文献
[1]Ended Clavien-Dindo classification of surgical complications:Japan Clinical Oncology Group postoperative complications criteria[J].Surg Today,2016,46:668-685.
[2]Sasako M,Sano T,Yamamoto S,et al.Japan Clinical Oncology Group(JCOG9502):Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia:A randomized controlled trial[J].Lancet Oncol,2006,7:644-651.
[3]Cuschieri A.Patient suivival after D1 and D2 resections for gastric cancer:long-term results of the MRC randomized surgical trial.Surgical co-operative[J].Br J Cancer,1999,79(9-10):1522-1530.
[4]Bonenkamp JJ.Extended lymph-node dissection for gastric cancer[J].N Engl J Med,1999,340 (12):908-914.
[5]Lee KG,Lee HJ,Yang JY,et al.Risk Factors Associated with Complication Following Gastrectomy for Gastric Cancer:Retrospective Analysis of Prospectively Collected Data Based on the Clavien-dindo System[J].J Gastrointest Surg,2014; 18:1269-1277.
[6]Sano T,Sasako T,Shibata S,et al.Randomized controlled trial to eraluate splenectomy in total gastrectomy for proyimal gastric carcinoma(JCOG0110):Analyses of operative morbidity,operative time and blood loss[J].J Clin Oncol.,2010,28:153(Suppl:abstr 4020).
[7]Terashima M,Doki Y,Kurokawa Y,et al.Primary results of a phase Ⅲ trial to evaluate bursectomy for patients with subserosal/serosal gastric cancer (JCOG1001)[J].Journal of Clinical Oncology,2017,35 (4_suppl):5.
[8]Watanabe MY,Miyata HA,Gotoh MK,et al.Total Gastrectomy Risk Model Data From 20,011 Japanese Patients in a Nationwide internet-Based Database[J].Ann Surg 2014; 260:1034-1039.
[9]Inaki NY,Etoh TY,Ohyama TJ,et al.A Multi-institutional Prospective phase Ⅱ Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG-0901)[J].World J Surg,2015,39:2734-2741.
[10]Kim HH,Hyung WJ,Cho GS,et al.Morbidity and Mortality of Laparoscopic Gastrectomy Versus Open Gastrctomy for Gastric Cancer[J].Ann Surg 2010; 251:417-420.(https://www.daowen.com)
[11]Kim W,Kim HH,Han SU,et al.Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer[J].Ann Surg 2016; 263:28-35.
[12]Dindo D,Demartinesw N,Clavien PA.Classification of surgical complications:a new proposal with evaluation in cohort of 6336 patients and results of a survey[J].Ann Surg 2004; 240:205-213.
[13]Sano T,Sasako M,Yamamoto S,et al.Gastri Cancer surgery:morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501[J].J Clin Oncol,2004,22:2767-2773.
[14]Luna A,Rebasa P,Navarro S,et al.An evaluation of morbidity and mortality in oncologic gastric surgery with the application of POSSUM,P-POSSUM and O-POSSUM[J].World J Surg.,2009,33(9):1889-1894.
[15]Haga Y,Ikei S,Ogawa M,Estimation of physiologic ability and surgical stress (E-PASS) as a new prediction scoring system for postoperative morbidity and mortality following elective gastrointestinal surgery[J].Surg Today 1999; 29:219-225.
[16]OhkuraY,Shinohara HS,Shindoh JC,et al.A New Scoring System Using Preoperative Factors and Contour Mapping for Predicting Postoperative Complications of Laparoscopic Gastrectomy[J].Dig Surg 2016; 33:74-81.
[17]黄昌明.腹腔镜胃癌手术常见并发症的预防和处理[J].中国微创外科杂志，2010,10(11):995-996.
[18]胡祥，张驰.胃癌根治术后并发症评价标准及风险预测[J].中华消化外科杂志，2018(6):540-545.
[19]张启瑜.钱礼腹部外科学[J].第2版.人民卫生出版社，2017.9.